These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 14072270)

  • 1. [BLOOD COAGULATION DISORDERS AND CORTISONE THERAPY IN GAUCHER'S DISEASE].
    SZILAGYI G; CZIRAKI L; RUTKAI P
    Z Gesamte Inn Med; 1963 Jul; 18():648-52. PubMed ID: 14072270
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in factors of the prothrombin complex (prothrombin, proconvertin, proaccelerin) in chronic hepatitis and cirrhosis].
    Stănescu M; Stroescu F
    Med Interna (Bucur); 1967 Apr; 19(4):417-23. PubMed ID: 6052153
    [No Abstract]   [Full Text] [Related]  

  • 3. A chronic clotting defect with some characteristics of excessive intravascular coagulation in a patient with Gaucher's disease.
    Vreeken J; Meinders AE; Keeman JN; Feltkamp TE
    Folia Med Neerl; 1967; 10(6):180-5. PubMed ID: 5590977
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on blood coagulation factors; factor V and factor VII complex. I. Studies on the assay of factor V and factor VII complex].
    Kubo K
    Naika Hokan; 1968 Apr; 15(4):95-102. PubMed ID: 5693429
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood coagulation disorders in acute pancreatitis].
    Gülzow M; Schulz K
    Z Gesamte Inn Med; 1965 Sep; 20(18):559-64. PubMed ID: 5879873
    [No Abstract]   [Full Text] [Related]  

  • 6. [STUDY OF SOME BLOOD COAGULATION INDICES IN PULMONARY TUBERCOLOSIS (WITH SPECIAL REFERENCE TO THE THROMBOELASTOGRAM)].
    TIGANO F; LAROSA F; BIONDO G
    Arch Tisiol Mal Appar Respir; 1964 Apr; 19():301-29. PubMed ID: 14217706
    [No Abstract]   [Full Text] [Related]  

  • 7. Coagulation abnormalities in type 1 Gaucher disease in children.
    Deghady A; Marzouk I; El-Shayeb A; Wali Y
    Pediatr Hematol Oncol; 2006; 23(5):411-7. PubMed ID: 16728361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of some blood coagulation factors in acute icterogenic hepatitis].
    Ravazzoni L; Casini E; Provvidenza G
    G Mal Infett Parassit; 1966 Oct; 18(10):666-8. PubMed ID: 5997195
    [No Abstract]   [Full Text] [Related]  

  • 9. The blood coagulation mechanism with especial reference to the prothrombin-proconvertin contents of plasma during long-term ACTH or cortisone therapy.
    FISCHER F; LUND E
    Acta Med Scand; 1954; 149(3):179-85. PubMed ID: 13180225
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenotypic continuum of type 2 Gaucher's disease: an intermediate phenotype between perinatal-lethal and classic type 2 Gaucher's disease.
    Ben Turkia H; Tebib N; Azzouz H; Abdelmoula MS; Ben Chehida A; Caillaud C; Ben Dridi MF
    J Perinatol; 2009 Feb; 29(2):170-2. PubMed ID: 19177047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disorders of hemostasis and respiratory distress in the newborn. Hyaline membrane disease and transient respiratory distress].
    Leroux B; Droulle-Bertignon C; Potron G; Ferrand O; Mesmin F
    Ann Pediatr (Paris); 1976 Feb; 23(2):89-96. PubMed ID: 16104234
    [No Abstract]   [Full Text] [Related]  

  • 13. Gaucher's disease and coagulation factors.
    Sawitsky A; Boklan BF
    Ann Intern Med; 1972 Jul; 77(1):150-1. PubMed ID: 5052441
    [No Abstract]   [Full Text] [Related]  

  • 14. [Disorders of hemostasis. Diagnosis and therapy].
    Pericoli Ridolfini F
    Policlinico Prat; 1972 Feb; 79(3):81-104. PubMed ID: 5012861
    [No Abstract]   [Full Text] [Related]  

  • 15. The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy.
    Elinav E; Ben-Dov I; Hai-Am E; Ackerman Z; Ofran Y
    J Hepatol; 2005 Jan; 42(1):82-6. PubMed ID: 15629511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaucher's disease and acquired coagulopathy.
    Humphries JE; Hess CE
    Am J Hematol; 1994 Apr; 45(4):347-8. PubMed ID: 8178808
    [No Abstract]   [Full Text] [Related]  

  • 17. Uveitis in Gaucher disease.
    Dweck A; Rozenman J; Ronen S; Zimran A; Elstein D
    Am J Ophthalmol; 2005 Jul; 140(1):146-7. PubMed ID: 16038664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gaucher disease: diagnosis and treatment].
    Fumić K; Stavljenić-Rukavina A; Mrsić M; Potocki K
    Acta Med Croatica; 2004; 58(5):353-8. PubMed ID: 15756799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibromyalgia and Gaucher's disease.
    Brautbar A; Elstein D; Pines B; Krienen N; Hemmer J; Buskila D; Zimran A
    QJM; 2006 Feb; 99(2):103-7. PubMed ID: 16293672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miglustat: new drug. In type 1 Gaucher's disease : a slight benefit after imiglucerase therapy.
    Prescrire Int; 2005 Oct; 14(79):168-70. PubMed ID: 16285070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.